Chronic Pain Treatment Market Research Report: By Product (Drugs, Devices), Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia), Application (Musculoskeletal, Neuropathy, Oncology), Distribution Channel (Direct, Indirect), End User (Hospitals, Clinics, Nursing Homes, Research Centers & Universities) - Global Industry Revenue Estimation and Demand Forecast to 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Indication

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by Distribution Channel

1.3.5 Market Segmentation by End User

1.3.6 Market Segmentation by Region

1.3.7 Analysis Period

1.3.8 Market Data Reporting Unit

1.3.8.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Drugs

4.1.1.1.1 Opioids

4.1.1.1.2 NSAIDs

4.1.1.1.3 Anticonvulsants

4.1.1.1.4 Antidepressants

4.1.1.1.5 Others

4.1.2 By Devices

4.1.2.1 Neurostimulation devices

4.1.2.1.1 SCS

4.1.2.1.2 TENS

4.1.2.1.3 Others

4.1.2.2 Analgesic infusion pumps

4.1.2.3 Ablation devices

4.1.2.3.1 Radiofrequency ablation devices

4.1.2.3.2 Cryoablation devices

4.1.3 By Indication

4.1.3.1 Neuropathic pain

4.1.3.2 Arthritis pain

4.1.3.3 Chronic back pain

4.1.3.4 Cancer pain

4.1.3.5 Migraine

4.1.3.6 Fibromyalgia

4.1.3.7 Others

4.1.4 By Application

4.1.4.1 Musculoskeletal

4.1.4.2 Neuropathy

4.1.4.3 Oncology

4.1.4.4 Others

4.1.5 By Distribution channel

4.1.5.1 Direct

4.1.5.2 Indirect

4.1.6 By End User

4.1.6.1 Hospitals

4.1.6.2 Clinics

4.1.6.3 Nursing homes

4.1.6.4 Research centers & universities

4.1.6.5 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Innovations in the field of pain management

4.2.1.2 Increasing number of product approvals

4.2.2 Drivers

4.2.2.1 Increasing government support for chronic pain management

4.2.2.2 Growing geriatric population

4.2.2.3 Surging prevalence of chronic health conditions

4.2.3 Impact Analysis of Drivers on Market Forecast

4.2.4 Restraints

4.2.4.1 Side effects associated with pain management drugs and devices

4.2.4.2 Product recalls

4.2.4.3 Patent expiry of blockbuster chronic pain treatment drugs

4.2.4.4 Increasing usage of opioids and antidepressants

4.2.5 Impact Analysis of Restraints on Market Forecast

4.3 Porter’s Five Forces Analysis

4.4 Impact of COVID-19

Chapter 5. Industry Insights

5.1 Pricing and Reimbursement Scenario

5.1.1 Pricing

5.1.2 Reimbursement Scenario

5.1.2.1 U.S.

5.1.2.2 Canada

5.1.2.3 Europe

5.1.2.3.1 Italy

5.1.2.3.2 Germany

5.1.2.3.3 U.K.

5.1.2.4 Japan

5.1.2.5 Australia

5.2 Research Funding and Government Initiatives

5.3 Pipeline Drugs for Chronic Pain

5.4 Key Products Expected to be Launched

5.5 Treatment

Chapter 6. Epidemiology Analysis

6.1 Number of People Reported with Chronic Pain in North America

6.1.1 U.S.

6.1.1.1 Patients visited healthcare facilities for the management of chronic pain in U.S.

6.1.1.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in U.S.

6.1.2 Canada

6.1.2.1 Patients visited healthcare facilities for the management of chronic pain in Canada

6.1.2.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Canada

6.2 Number of People Reported with Chronic Pain in Europe

6.2.1 Germany

6.2.1.1 Patients visited healthcare facilities for the management of chronic pain in Germany

6.2.1.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Germany

6.2.2 France

6.2.2.1 Patients visited healthcare facilities for the management of chronic pain in France

6.2.2.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in France

6.2.3 U.K.

6.2.3.1 Patients visited healthcare facilities for the management of chronic pain in U.K.

6.2.3.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in U.K.

6.2.4 Italy

6.2.4.1 Patients visited healthcare facilities for the management of chronic pain in Italy

6.2.4.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Italy

6.2.5 Spain

6.2.5.1 Patients visited healthcare facilities for the management of chronic pain in Spain

6.2.5.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Spain

6.2.6 Netherlands

6.2.6.1 Patients visited healthcare facilities for the management of chronic pain in Netherlands

6.2.6.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Netherlands

6.2.7 Russia

6.2.7.1 Patients visited healthcare facilities for the management of chronic pain in Russia

6.2.7.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Russia

6.2.8 Sweden

6.2.8.1 Patients visited healthcare facilities for the management of chronic pain in Sweden

6.2.8.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Sweden

6.2.9 Switzerland

6.2.9.1 Patients visited healthcare facilities for the management of chronic pain in Switzerland

6.2.9.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Switzerland

6.3 Number of People Reported with Chronic Pain in APAC

6.3.1 Japan

6.3.1.1 Patients visited healthcare facilities for the management of chronic pain in Japan

6.3.1.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Japan

6.3.2 China

6.3.2.1 Patients visited healthcare facilities for the management of chronic pain in China

6.3.2.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in China

6.3.3 India

6.3.3.1 Patients visited healthcare facilities for the management of chronic pain in India

6.3.3.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in India

6.3.4 Australia

6.3.4.1 Patients visited healthcare facilities for the management of chronic pain in Australia

6.3.4.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Australia

6.3.5 South Korea

6.3.5.1 Patients visited healthcare facilities for the management of chronic pain in South Korea

6.3.5.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in South Korea

6.4 Number of People Reported with Chronic Pain in LATAM

6.4.1 Brazil

6.4.1.1 Patients visited healthcare facilities for the management of chronic pain in Brazil

6.4.1.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Brazil

6.4.2 Mexico

6.4.2.1 Patients visited healthcare facilities for the management of chronic pain in Mexico

6.4.2.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Mexico

6.5 Number of People Reported with Chronic Pain in MEA

6.5.1 Saudi Arabia

6.5.1.1 Patients visited healthcare facilities for the management of chronic pain in Saudi Arabia

6.5.1.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in Saudi Arabia

6.5.2 South Africa

6.5.2.1 Patients visited healthcare facilities for the management of chronic pain in South Africa

6.5.2.1.1 Percentage of patients visited different healthcare settings for management of chronic pain in South Africa

Chapter 7. Global Market Size and Forecast

7.1 By Product

7.1.1 Chronic Pain Drugs Market, by Type

7.1.2 Chronic Pain Devices Market, by Type

7.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

7.1.2.2 Ablation devices market for chronic pain treatment, by type

7.2 By Indication

7.3 By Application

7.4 By Distribution Channel

7.5 By End User

7.6 By Region

Chapter 8. North America Market Size and Forecast

8.1 By Product

8.1.1 Chronic Pain Drugs Market, by Type

8.1.2 Chronic Pain Devices Market, by Type

8.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

8.1.2.2 Ablation devices market for chronic pain treatment, by type

8.2 By Indication

8.3 By Application

8.4 By Distribution Channel

8.5 By End User

8.6 By Country

8.6.1 U.S. Market Size and Forecast

8.6.1.1 By product

8.6.1.1.1 Chronic pain drugs market, by type

8.6.1.1.2 Chronic pain devices market, by type

8.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

8.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type

8.6.1.2 By indication

8.6.1.3 By application

8.6.1.4 By distribution channel

8.6.1.5 By end user

8.6.2 Canada Market Size and Forecast

8.6.2.1 By product

8.6.2.1.1 Chronic pain drugs market, by type

8.6.2.1.2 Chronic pain devices market, by type

8.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

8.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type

8.6.2.2 By indication

8.6.2.3 By application

8.6.2.4 By distribution channel

8.6.2.5 By end user

Chapter 9. Europe Market Size and Forecast

9.1 By Product

9.1.1 Chronic Pain Drugs Market, by Type

9.1.2 Chronic Pain Devices Market, by Type

9.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.1.2.2 Ablation devices market for chronic pain treatment, by type

9.2 By Indication

9.3 By Application

9.4 By Distribution Channel

9.5 By End User

9.6 By Country

9.6.1 Germany Market Size and Forecast

9.6.1.1 By product

9.6.1.1.1 Chronic pain drugs market, by type

9.6.1.1.2 Chronic pain devices market, by type

9.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.1.2 By indication

9.6.1.3 By application

9.6.1.4 By distribution channel

9.6.1.5 By end user

9.6.2 France Market Size and Forecast

9.6.2.1 By product

9.6.2.1.1 Chronic pain drugs market, by type

9.6.2.1.2 Chronic pain devices market, by type

9.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.2.2 By indication

9.6.2.3 By application

9.6.2.4 By distribution channel

9.6.2.5 By end user

9.6.3 U.K. Market Size and Forecast

9.6.3.1 By product

9.6.3.1.1 Chronic pain drugs market, by type

9.6.3.1.2 Chronic pain devices market, by type

9.6.3.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.3.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.3.2 By indication

9.6.3.3 By application

9.6.3.4 By distribution channel

9.6.3.5 By end user

9.6.4 Italy Market Size and Forecast

9.6.4.1 By product

9.6.4.1.1 Chronic pain drugs market, by type

9.6.4.1.2 Chronic pain devices market, by type

9.6.4.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.4.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.4.2 By indication

9.6.4.3 By application

9.6.4.4 By distribution channel

9.6.4.5 By end user

9.6.5 Spain Market Size and Forecast

9.6.5.1 By product

9.6.5.1.1 Chronic pain drugs market, by type

9.6.5.1.2 Chronic pain devices market, by type

9.6.5.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.5.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.5.2 By indication

9.6.5.3 By application

9.6.5.4 By distribution channel

9.6.5.5 By end user

9.6.6 Netherlands Market Size and Forecast

9.6.6.1 By product

9.6.6.1.1 Chronic pain drugs market, by type

9.6.6.1.2 Chronic pain devices market, by type

9.6.6.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.6.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.6.2 By indication

9.6.6.3 By application

9.6.6.4 By distribution channel

9.6.6.5 By end user

9.6.7 Russia Market Size and Forecast

9.6.7.1 By product

9.6.7.1.1 Chronic pain drugs market, by type

9.6.7.1.2 Chronic pain devices market, by type

9.6.7.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.7.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.7.2 By indication

9.6.7.3 By application

9.6.7.4 By distribution channel

9.6.7.5 By end user

9.6.8 Sweden Market Size and Forecast

9.6.8.1 By product

9.6.8.1.1 Chronic pain drugs market, by type

9.6.8.1.2 Chronic pain devices market, by type

9.6.8.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.8.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.8.2 By indication

9.6.8.3 By application

9.6.8.4 By distribution channel

9.6.8.5 By end user

9.6.9 Switzerland Market Size and Forecast

9.6.9.1 By product

9.6.9.1.1 Chronic pain drugs market, by type

9.6.9.1.2 Chronic pain devices market, by type

9.6.9.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

9.6.9.1.2.2 Ablation devices market for chronic pain treatment, by type

9.6.9.2 By indication

9.6.9.3 By application

9.6.9.4 By distribution channel

9.6.9.5 By end user

Chapter 10. APAC Market Size and Forecast

10.1 By Product

10.1.1 Chronic Pain Drugs Market, by Type

10.1.2 Chronic Pain Devices Market, by Type

10.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

10.1.2.2 Ablation devices market for chronic pain treatment, by type

10.2 By Indication

10.3 By Application

10.4 By Distribution Channel

10.5 By End User

10.6 By Country

10.6.1 Japan Market Size and Forecast

10.6.1.1 By product

10.6.1.1.1 Chronic pain drugs market, by type

10.6.1.1.2 Chronic pain devices market, by type

10.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

10.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type

10.6.1.2 By indication

10.6.1.3 By application

10.6.1.4 By distribution channel

10.6.1.5 By end user

10.6.2 China Market Size and Forecast

10.6.2.1 By product

10.6.2.1.1 Chronic pain drugs market, by type

10.6.2.1.2 Chronic pain devices market, by type

10.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

10.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type

10.6.2.2 By indication

10.6.2.3 By application

10.6.2.4 By distribution channel

10.6.2.5 By end user

10.6.3 India Market Size and Forecast

10.6.3.1 By product

10.6.3.1.1 Chronic pain drugs market, by type

10.6.3.1.2 Chronic pain devices market, by type

10.6.3.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

10.6.3.1.2.2 Ablation devices market for chronic pain treatment, by type

10.6.3.2 By indication

10.6.3.3 By application

10.6.3.4 By distribution channel

10.6.3.5 By end user

10.6.4 Australia Market Size and Forecast

10.6.4.1 By product

10.6.4.1.1 Chronic pain drugs market, by type

10.6.4.1.2 Chronic pain devices market, by type

10.6.4.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

10.6.4.1.2.2 Ablation devices market for chronic pain treatment, by type

10.6.4.2 By indication

10.6.4.3 By application

10.6.4.4 By distribution channel

10.6.4.5 By end user

10.6.5 South Korea Market Size and Forecast

10.6.5.1 By product

10.6.5.1.1 Chronic pain drugs market, by type

10.6.5.1.2 Chronic pain devices market, by type

10.6.5.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

10.6.5.1.2.2 Ablation devices market for chronic pain treatment, by type

10.6.5.2 By indication

10.6.5.3 By application

10.6.5.4 By distribution channel

10.6.5.5 By end user

Chapter 11. LATAM Market Size and Forecast

11.1 By Product

11.1.1 Chronic Pain Drugs Market, by Type

11.1.2 Chronic Pain Devices Market, by Type

11.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

11.1.2.2 Ablation devices market for chronic pain treatment, by type

11.2 By Indication

11.3 By Application

11.4 By Distribution Channel

11.5 By End User

11.6 By Country

11.6.1 Brazil Market Size and Forecast

11.6.1.1 By product

11.6.1.1.1 Chronic pain drugs market, by type

11.6.1.1.2 Chronic pain devices market, by type

11.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

11.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type

11.6.1.2 By indication

11.6.1.3 By application

11.6.1.4 By distribution channel

11.6.1.5 By end user

11.6.2 Mexico Market Size and Forecast

11.6.2.1 By product

11.6.2.1.1 Chronic pain drugs market, by type

11.6.2.1.2 Chronic pain devices market, by type

11.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

11.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type

11.6.2.2 By indication

11.6.2.3 By application

11.6.2.4 By distribution channel

11.6.2.5 By end user

Chapter 12. MEA Market Size and Forecast

12.1 By Product

12.1.1 Chronic Pain Drugs Market, by Type

12.1.2 Chronic Pain Devices Market, by Type

12.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

12.1.2.2 Ablation devices market for chronic pain treatment, by type

12.2 By Indication

12.3 By Application

12.4 By Distribution Channel

12.5 By End User

12.6 By Country

12.6.1 Saudi Arabia Market Size and Forecast

12.6.1.1 By product

12.6.1.1.1 Chronic pain drugs market, by type

12.6.1.1.2 Chronic pain devices market, by type

12.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

12.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type

12.6.1.2 By indication

12.6.1.3 By application

12.6.1.4 By distribution channel

12.6.1.5 By end user

12.6.2 South Africa Market Size and Forecast

12.6.2.1 By product

12.6.2.1.1 Chronic pain drugs market, by type

12.6.2.1.2 Chronic pain devices market, by type

12.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type

12.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type

12.6.2.2 By indication

12.6.2.3 By application

12.6.2.4 By distribution channel

12.6.2.5 By end user

Chapter 13. Competitive Landscape

13.1 Product Benchmarking of Key Players

13.2 Strategic Developments of Key Players

13.2.1 Partnerships, Collaborations, and Agreements

13.2.2 Mergers and Acquisitions

13.2.3 Product Launches and Approvals

Chapter 14. Company Profiles

14.1 Eli Lilly and Company

14.1.1 Business Overview

14.1.2 Product and Service Offerings

14.1.2.1 Marketed products

14.1.2.2 Pipeline products

14.1.3 Key Financial Summary

14.2 GlaxoSmithKline plc

14.2.1 Business Overview

14.2.2 Product and Service Offerings

14.2.2.1 Marketed products

14.2.2.2 Pipeline products

14.2.3 Key Financial Summary

14.3 Pfizer Inc.

14.3.1 Business Overview

14.3.2 Product and Service Offerings

14.3.2.1 Marketed products

14.3.2.2 Pipeline products

14.3.3 Key Financial Summary

14.4 Medtronic plc

14.4.1 Business Overview

14.4.2 Product and Service Offerings

14.4.3 Key Financial Summary

14.5 Abbott Laboratories

14.5.1 Business Overview

14.5.2 Product and Service Offerings

14.5.3 Key Financial Summary

14.6 Boston Scientific Corporation

14.6.1 Business Overview

14.6.2 Product and Service Offerings

14.6.3 Key Financial Summary

14.7 Novartis AG

14.7.1 Business Overview

14.7.2 Product and Service Offerings

14.7.2.1 Marketed products

14.7.2.2 Pipeline products

14.7.3 Key Financial Summary

14.8 Johnson & Johnson

14.8.1 Business Overview

14.8.2 Product and Service Offerings

14.8.2.1 Marketed products

14.8.2.2 Pipeline products

14.8.3 Key Financial Summary

14.9 AstraZeneca plc

14.9.1 Business Overview

14.9.2 Product and Service Offerings

14.9.2.1 Marketed products

14.9.2.2 Pipeline products

14.9.3 Key Financial Summary

14.10 Bristol-Myers Squibb Company

14.10.1 Business Overview

14.10.2 Product and Service Offerings

14.10.2.1 Marketed products

14.10.2.2 Pipeline products

14.10.3 Key Financial Summary

14.11 Becton, Dickinson and Company

14.11.1 Business Overview

14.11.2 Product and Service Offerings

14.11.3 Key Financial Summary

14.12 Sanofi S.A.

14.12.1 Business Overview

14.12.2 Product and Service Offerings

14.12.2.1 Marketed products

14.12.2.2 Pipeline products

14.12.3 Key Financial Summary

Chapter 15. Appendix

15.1 Abbreviations

15.2 Sources and References

15.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 PATENT EXPIRATION OF SOME CHRONIC PAIN TREATMENT DRUGS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 PRICE LISTING OF SOME MARKETED DRUGS FOR CHRONIC PAIN TREATMENT

TABLE 6 PRICE LISTING OF SOME MARKETED DEVICES FOR CHRONIC PAIN TREATMENT

TABLE 7 NEUROMODULATION MEDICARE PAYMENTS GUIDE – SPICAL CORD SIMULATION (SCS) – HOSPITAL SIMULATION (2021)

TABLE 8 LIST OF DRUGS UNDER REGULATORY REVIEW, PRE-REGISTRATION, AND FILED STAGES

TABLE 9 LIST OF DRUGS IN PHASE III STAGE OF DEVELOPMENT

TABLE 10 LIST OF DRUGS IN PHASE II STAGE OF DEVELOPMENT

TABLE 11 LIST OF DRUGS IN PHASE I STAGE OF DEVELOPMENT

TABLE 12 LIST OF DRUGS IN PRE-CLINICAL STAGE OF DEVELOPMENT

TABLE 13 LIST OF DISCOVERY DRUGS

TABLE 14 LIST OF DRUGS FOR WHICH NEW DRUG APPLICATION (NDA) HAS BEEN FILED

TABLE 15 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN NORTH AMERICA, IN MILLION (2015–2020)

TABLE 16 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN NORTH AMERICA, IN MILLION (2015–2020)

TABLE 17 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN NORTH AMERICA, IN MILLION (2026–2030)

TABLE 18 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN U.S., IN MILLION (2020)

TABLE 19 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN U.S.

TABLE 20 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN CANADA, IN MILLION (2020)

TABLE 21 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN CANADA

TABLE 22 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN EUROPE, IN MILLION (2015–2020)

TABLE 23 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN EUROPE, IN MILLION (2021–2025)

TABLE 24 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN EUROPE, IN MILLION (2026–2030)

TABLE 25 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN GERMANY, IN MILLION (2020)

TABLE 26 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN GERMANY

TABLE 27 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN FRANCE, IN MILLION (2020)

TABLE 28 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN FRANCE

TABLE 29 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN U.K., IN MILLION (2020)

TABLE 30 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN U.K.

TABLE 31 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN ITALY, IN MILLION (2020)

TABLE 32 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN ITALY

TABLE 33 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN SPAIN, IN MILLION (2020)

TABLE 34 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN SPAIN

TABLE 35 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN NETHERLANDS, IN MILLION (2020)

TABLE 36 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN NETHERLANDS

TABLE 37 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN RUSSIA, IN MILLION (2020)

TABLE 38 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN RUSSIA

TABLE 39 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN SWEDEN, IN MILLION (2020)

TABLE 40 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN SWEDEN

TABLE 41 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN SWITZERLAND, IN MILLION (2020)

TABLE 42 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN SWITZERLAND

TABLE 43 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN APAC, IN MILLION (2015–2020)

TABLE 44 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN APAC, IN MILLION (2021–2025)

TABLE 45 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN APAC, IN MILLION (2026–2030)

TABLE 46 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN JAPAN, IN MILLION (2020)

TABLE 47 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN JAPAN

TABLE 48 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN CHINA, IN MILLION (2020)

TABLE 49 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN CHINA

TABLE 50 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN INDIA, IN MILLION (2020)

TABLE 51 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN INDIA

TABLE 52 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN AUSTRALIA, IN MILLION (2020)

TABLE 53 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN AUSTRALIA

TABLE 54 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN SOUTH KOREA, IN MILLION (2020)

TABLE 55 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN SOUTH KOREA

TABLE 56 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN LATAM, IN MILLION (2015–2020)

TABLE 57 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN LATAM, IN MILLION (2021–2025)

TABLE 58 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN LATAM, IN MILLION (2026–2030)

TABLE 59 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN BRAZIL, IN MILLION (2020)

TABLE 60 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN BRAZIL

TABLE 61 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN MEXICO, IN MILLION (2020)

TABLE 62 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN MEXICO

TABLE 63 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN MEA, IN MILLION (2015–2020)

TABLE 64 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN MEA, IN MILLION (2021–2025)

TABLE 65 NUMBER OF PEOPLE REPORTED WITH CHRONIC PAIN IN MEA, IN MILLION (2026–2030)

TABLE 66 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN SAUDI ARABIA, IN MILLION (2020)

TABLE 67 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN SAUDI ARABIA

TABLE 68 NUMBER OF PATIENTS VISITED HEALTHCARE FACILITIES FOR THE MANAGEMENT OF CHRONIC PAIN IN SOUTH AFRICA, IN MILLION (2020)

TABLE 69 PERCENTAGE OF PATIENTS VISITED DIFFERENT HEALTHCARE SETTINGS FOR MANAGEMENT OF CHRONIC PAIN IN SOUTH AFRICA

TABLE 70 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 71 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 72 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 73 GLOBAL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 74 GLOBAL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 75 GLOBAL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 76 GLOBAL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 77 GLOBAL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 78 GLOBAL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 79 GLOBAL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 80 GLOBAL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 81 GLOBAL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 82 GLOBAL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 83 GLOBAL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 84 GLOBAL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 85 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 86 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 87 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 88 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 89 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 90 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 91 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 92 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 93 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 94 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 95 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 96 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 97 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY REGION, $M (2015–2020)

TABLE 98 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY REGION, $M (2021–2030)

TABLE 99 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY REGION, $M (2026–2030)

TABLE 100 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 101 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 102 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 103 NORTH AMERICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 104 NORTH AMERICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 105 NORTH AMERICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 106 NORTH AMERICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 107 NORTH AMERICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 108 NORTH AMERICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 109 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 110 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 111 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 112 NORTH AMERICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 113 NORTH AMERICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 114 NORTH AMERICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 115 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 116 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 117 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 118 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 119 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 120 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 121 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 122 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 123 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 124 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 125 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 126 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 127 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2020)

TABLE 128 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2021–2025)

TABLE 129 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2026–2030)

TABLE 130 U.S. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 131 U.S. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 132 U.S. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 133 U.S. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 134 U.S. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 135 U.S. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 136 U.S. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 137 U.S. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 138 U.S. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 139 U.S. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 140 U.S. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 141 U.S. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 142 U.S. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 143 U.S. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 144 U.S. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 145 U.S. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 146 U.S. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 147 U.S. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 148 U.S. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 149 U.S. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 150 U.S. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 151 U.S. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 152 U.S. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 153 U.S. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 154 U.S. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 155 U.S. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 156 U.S. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 157 CANADA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 158 CANADA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 159 CANADA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 160 CANADA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 161 CANADA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 162 CANADA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 163 CANADA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 164 CANADA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 165 CANADA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 166 CANADA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 167 CANADA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 168 CANADA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 169 CANADA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 170 CANADA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 171 CANADA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 172 CANADA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 173 CANADA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 174 CANADA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 175 CANADA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 176 CANADA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 177 CANADA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 178 CANADA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 179 CANADA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 180 CANADA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 181 CANADA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 182 CANADA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 183 CANADA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 184 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 185 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 186 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 187 EUROPE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 188 EUROPE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 189 EUROPE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 190 EUROPE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 191 EUROPE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 192 EUROPE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 193 EUROPE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 194 EUROPE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 195 EUROPE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 196 EUROPE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 197 EUROPE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 198 EUROPE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 199 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 200 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 201 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 202 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 203 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 204 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 205 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 206 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 207 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 208 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 209 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 210 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 211 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2020)

TABLE 212 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2021–2025)

TABLE 213 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2026–2030)

TABLE 214 GERMANY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 215 GERMANY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 216 GERMANY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 217 GERMANY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 218 GERMANY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 219 GERMANY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 220 GERMANY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 221 GERMANY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 222 GERMANY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 223 GERMANY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 224 GERMANY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 225 GERMANY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 226 GERMANY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 227 GERMANY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 228 GERMANY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 229 GERMANY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 230 GERMANY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 231 GERMANY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 232 GERMANY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 233 GERMANY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 234 GERMANY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 235 GERMANY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 236 GERMANY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 237 GERMANY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 238 GERMANY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 239 GERMANY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 240 GERMANY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 241 FRANCE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 242 FRANCE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 243 FRANCE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 244 FRANCE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 245 FRANCE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 246 FRANCE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 247 FRANCE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 248 FRANCE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 249 FRANCE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 250 FRANCE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 251 FRANCE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 252 FRANCE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 253 FRANCE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 254 FRANCE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 255 FRANCE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 256 FRANCE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 257 FRANCE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 258 FRANCE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 259 FRANCE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 260 FRANCE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 261 FRANCE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 262 FRANCE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 263 FRANCE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 264 FRANCE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 265 FRANCE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 266 FRANCE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 267 FRANCE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 268 U.K. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 269 U.K. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 270 U.K. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 271 U.K. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 272 U.K. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 273 U.K. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 274 U.K. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 275 U.K. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 276 U.K. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 277 U.K. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 278 U.K. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 279 U.K. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 280 U.K. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 281 U.K. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 282 U.K. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 283 U.K. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 284 U.K. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 285 U.K. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 286 U.K. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 287 U.K. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 288 U.K. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 289 U.K. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 290 U.K. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 291 U.K. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 292 U.K. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 293 U.K. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 294 U.K. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 295 ITALY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 296 ITALY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 297 ITALY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 298 ITALY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 299 ITALY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 300 ITALY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 301 ITALY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 302 ITALY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 303 ITALY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 304 ITALY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 305 ITALY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 306 ITALY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 307 ITALY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 308 ITALY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 309 ITALY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 310 ITALY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 311 ITALY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 312 ITALY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 313 ITALY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 314 ITALY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 315 ITALY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 316 ITALY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 317 ITALY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 318 ITALY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 319 ITALY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 320 ITALY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 321 ITALY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 322 SPAIN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 323 SPAIN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 324 SPAIN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 325 SPAIN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 326 SPAIN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 327 SPAIN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 328 SPAIN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 329 SPAIN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 330 SPAIN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 331 SPAIN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 332 SPAIN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 333 SPAIN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 334 SPAIN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 335 SPAIN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 336 SPAIN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 337 SPAIN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 338 SPAIN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 339 SPAIN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 340 SPAIN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 341 SPAIN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 342 SPAIN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 343 SPAIN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 344 SPAIN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 345 SPAIN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 346 SPAIN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 347 SPAIN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 348 SPAIN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 349 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 350 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 351 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 352 NETHERLANDS CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 353 NETHERLANDS CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 354 NETHERLANDS CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 355 NETHERLANDS CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 356 NETHERLANDS CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 357 NETHERLANDS CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 358 NETHERLANDS NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 359 NETHERLANDS NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 360 NETHERLANDS NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 361 NETHERLANDS ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 362 NETHERLANDS ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 363 NETHERLANDS ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 364 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 365 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 366 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 367 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 368 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 369 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 370 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 371 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 372 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 373 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 374 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2026)

TABLE 375 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 376 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 377 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 378 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 379 RUSSIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 380 RUSSIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 381 RUSSIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 382 RUSSIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 383 RUSSIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 384 RUSSIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 385 RUSSIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 386 RUSSIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 387 RUSSIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 388 RUSSIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 389 RUSSIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 390 RUSSIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 391 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 392 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 393 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 394 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 395 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 396 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 397 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 398 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 399 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 400 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 401 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 402 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 403 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 404 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 405 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 406 SWEDEN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 407 SWEDEN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 408 SWEDEN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 409 SWEDEN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 410 SWEDEN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 411 SWEDEN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 412 SWEDEN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 413 SWEDEN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 414 SWEDEN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 415 SWEDEN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 416 SWEDEN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 417 SWEDEN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 418 SWEDEN CHRONC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 419 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 420 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 421 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 422 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 423 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 424 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 425 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 426 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 427 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 428 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 429 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 430 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 431 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 432 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 433 SWITZERLAND CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 434 SWITZERLAND CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 435 SWITZERLAND CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 436 SWITZERLAND CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 437 SWITZERLAND CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 438 SWITZERLAND CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 439 SWITZERLAND NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 440 SWITZERLAND NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 441 SWITZERLAND NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 442 SWITZERLAND ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 443 SWITZERLAND ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 444 SWITZERLAND ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 445 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 446 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 447 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 448 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 449 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 450 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 451 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 452 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 453 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 454 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 455 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 456 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 457 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 458 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 459 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 460 APAC CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 461 APAC CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 462 APAC CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 463 APAC CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 464 APAC CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 465 APAC CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 466 APAC NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 467 APAC NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 468 APAC NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 469 APAC ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 470 APAC ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 471 APAC ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 472 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 473 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 474 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 475 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 476 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 477 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 478 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 479 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 480 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 481 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 482 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 483 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 484 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2020)

TABLE 485 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2021–2025)

TABLE 486 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2026–2030)

TABLE 487 JAPAN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 488 JAPAN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 489 JAPAN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 490 JAPAN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 491 JAPAN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 492 JAPAN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 493 JAPAN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 494 JAPAN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 495 JAPAN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 496 JAPAN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 497 JAPAN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 498 JAPAN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 499 JAPAN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 500 JAPAN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 501 JAPAN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 502 JAPAN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 503 JAPAN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 504 JAPAN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 505 JAPAN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 506 JAPAN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 507 JAPAN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 508 JAPAN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 509 JAPAN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 510 JAPAN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 511 JAPAN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 512 JAPAN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 513 JAPAN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 514 CHINA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 515 CHINA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 516 CHINA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 517 CHINA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 518 CHINA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 519 CHINA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 520 CHINA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 521 CHINA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 522 CHINA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 523 CHINA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 524 CHINA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 525 CHINA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 526 CHINA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 527 CHINA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 528 CHINA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 529 CHINA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 530 CHINA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 531 CHINA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 532 CHINA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 533 CHINA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2030)

TABLE 534 CHINA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 535 CHINA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 536 CHINA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 537 CHINA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 538 CHINA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 539 CHINA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 540 . CHINA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 541 INDIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 542 INDIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 543 INDIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 544 INDIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 545 INDIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 546 INDIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 547 INDIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 548 INDIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 549 INDIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 550 INDIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 551 INDIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2030)

TABLE 552 INDIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 553 INDIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 554 INDIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 555 INDIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 556 INDIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 557 INDIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 558 INDIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 559 INDIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 560 INDIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 561 INDIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 562 INDIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 563 INDIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 564 INDIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 565 INDIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 566 INDIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 567 INDIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 568 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 569 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 570 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 571 AUSTRALIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 572 AUSTRALIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 573 AUSTRALIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 574 AUSTRALIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 575 AUSTRALIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 576 AUSTRALIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 577 AUSTRALIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 578 AUSTRALIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 579 AUSTRALIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 580 AUSTRALIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 581 AUSTRALIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2021)

TABLE 582 AUSTRALIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 583 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 584 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 585 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 586 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 587 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 588 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 589 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 590 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 591 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 592 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 593 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 594 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 595 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 596 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 597 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 598 SOUTH KOREA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 599 SOUTH KOREA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 600 SOUTH KOREA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 601 SOUTH KOREA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 602 SOUTH KOREA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 603 SOUTH KOREA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 604 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 605 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 606 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 607 SOUTH KOREA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 608 SOUTH KOREA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 609 SOUTH KOREA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 610 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 611 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 612 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 613 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 614 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 615 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 616 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 617 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 618 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 619 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 620 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 621 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 622 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 623 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 624 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 625 LATAM CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 626 LATAM CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 627 LATAM CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 628 LATAM CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 629 LATAM CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2030)

TABLE 630 LATAM CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 631 LATAM NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 632 LATAM NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 633 LATAM NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 634 LATAM ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 635 LATAM ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 636 LATAM ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 637 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 638 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 639 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 640 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 641 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 642 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 643 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 644 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 645 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 646 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 647 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 648 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 649 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2020)

TABLE 650 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2021–2025)

TABLE 651 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2026–2030)

TABLE 652 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 653 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 654 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 655 BRAZIL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 656 BRAZIL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 657 BRAZIL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 658 BRAZIL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 659 BRAZIL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 660 BRAZIL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 661 BRAZIL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 662 BRAZIL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 663 BRAZIL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 664 BRAZIL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 665 BRAZIL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 666 BRAZIL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 667 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 668 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 669 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 670 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 671 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 672 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 673 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 674 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 675 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 676 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 677 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 678 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 679 MEXICO CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 680 MEXICO CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 681 MEXICO CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 682 MEXICO CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 683 MEXICO CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 684 MEXICO CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 685 MEXICO CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 686 MEXICO CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 687 MEXICO CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 688 MEXICO NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 689 MEXICO NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 690 MEXICO NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 691 MEXICO ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 692 MEXICO ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 693 MEXICO ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 694 MEXICO CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 695 MEXICO CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 696 MEXICO CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 697 MEXICO CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 698 MEXICO CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 699 MEXICO CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 700 MEXICO CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 701 MEXICO CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 702 MEXICO CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 703 MEXICO CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 704 MEXICO CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 705 MEXICO CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 706 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 707 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 708 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 709 MEA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 710 MEA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 711 MEA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 712 MEA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 713 MEA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 714 MEA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 715 MEA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 716 MEA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 717 MEA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2025–2030)

TABLE 718 MEA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 719 MEA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 720 MEA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 721 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 722 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 723 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 724 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 725 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 726 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 727 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 728 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 729 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 730 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 731 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 732 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 733 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2020)

TABLE 734 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2021–2025)

TABLE 735 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2026–2030)

TABLE 736 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 737 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 738 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 739 SAUDI ARABIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 740 SAUDI ARABIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 741 SAUDI ARABIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 742 SAUDI ARABIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 743 SAUDI ARABIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 744 SAUDI ARABIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 745 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 746 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 747 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 748 SAUDI ARABIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 749 SAUDI ARABIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 750 SAUDI ARABIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 751 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 752 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 753 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 754 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 755 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 756 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 757 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 758 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 759 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 760 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 761 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 762 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 763 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2020)

TABLE 764 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2021–2025)

TABLE 765 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2026–2030)

TABLE 766 SOUTH AFRICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2015–2020)

TABLE 767 SOUTH AFRICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2021–2025)

TABLE 768 SOUTH AFRICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2026–2030)

TABLE 769 SOUTH AFRICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2015–2020)

TABLE 770 SOUTH AFRICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2021–2025)

TABLE 771 SOUTH AFRICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2026–2030)

TABLE 772 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 773 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 774 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 775 SOUTH AFRICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2015–2020)

TABLE 776 SOUTH AFRICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2021–2025)

TABLE 777 SOUTH AFRICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2026–2030)

TABLE 778 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2020)

TABLE 779 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2021–2025)

TABLE 780 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2026–2030)

TABLE 781 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2020)

TABLE 782 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2021–2025)

TABLE 783 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2026–2030)

TABLE 784 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2020)

TABLE 785 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2021–2025)

TABLE 786 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2026–2030)

TABLE 787 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2020)

TABLE 788 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2021–2025)

TABLE 789 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2026–2030)

TABLE 790 ELI LILLY AND COMPANY – AT A GLANCE

TABLE 791 ELI LILLY AND COMPANY – KEY FINANCIAL SUMMARY

TABLE 792 GLAXOSMITHKLINE PLC – AT A GLANCE

TABLE 793 GLAXOSMITHKLINE PLC – KEY FINANCIAL SUMMARY

TABLE 794 PFIZER INC. – AT A GLANCE

TABLE 795 PFIZER INC. – KEY FINANCIAL SUMMARY

TABLE 796 MEDTRONIC PLC – AT A GLANCE

TABLE 797 MEDTRONIC PLC – KEY FINANCIAL SUMMARY

TABLE 798 ABBOTT LABORATORIES – AT A GLANCE

TABLE 799 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY

TABLE 800 BOSTON SCIENTIFIC CORPORATION – AT A GLANCE

TABLE 801 BOSTON SCIENTIFIC COPORATION – KEY FINANCIAL SUMMARY

TABLE 802 NOVARTIS AG – AT A GLANCE

TABLE 803 NOVARTIS AG – KEY FINANCIAL SUMMARY

TABLE 804 JOHNSON & JOHNSON – AT A GLANCE

TABLE 805 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY

TABLE 806 ASTRAZENECA PLC – AT A GLANCE

TABLE 807 ASTRAZENECA PLC – KEY FINANCIAL SUMMARY

TABLE 808 BRISTOL-MYERS SQUIBB COMPANY – AT A GLANCE

TABLE 809 BRISTOL-MYERS SQUIBB COMPANY – KEY FINANCIAL SUMMARY

TABLE 810 BECTON, DICKINSON AND COMPANY – AT A GLANCE

TABLE 811 BECTON, DICKINSON AND COMPANY – KEY FINANCIAL SUMMARY

TABLE 812 SANOFI S.A. – AT A GLANCE

TABLE 813 SANOFI S.A. – KEY FINANCIAL SUMMAR

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL CHRONIC PAIN TREATMENT MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 INTENSITY OF RIVALRY

FIG 12 THREAT OF NEW ENTRANTS

FIG 13 THREAT OF SUBSTITUTES

FIG 14 TREATMENT PROCEDURES FOR CHRONIC PAIN

FIG 15 SNAPSHOT OF GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, 2020

FIG 16 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2030)

FIG 17 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2030)

FIG 18 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2030)

FIG 19 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2030)

FIG 20 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2030)

FIG 21 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET SNAPSHOT

FIG 22 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2030)

FIG 23 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2030)

FIG 24 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2030)

FIG 25 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2030)

FIG 26 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2030)

FIG 27 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2030)

FIG 28 EUROPE CHRONIC PAIN TREATMENT MARKET SNAPSHOT

FIG 29 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2030)

FIG 30 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2030)

FIG 31 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2030)

FIG 32 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2030)

FIG 33 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2030)

FIG 34 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2030)

FIG 35 APAC CHRONIC PAIN TREATMENT MARKET SNAPSHOT

FIG 36 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2030)

FIG 37 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2030)

FIG 38 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2030)

FIG 39 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2030)

FIG 40 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2030)

FIG 41 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2030)

FIG 42 LATAM CHRONIC PAIN TREATMENT MARKET SNAPSHOT

FIG 43 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2030)

FIG 44 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2030)

FIG 45 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2030)

FIG 46 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2030)

FIG 47 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2030)

FIG 48 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2030)

FIG 49 MEA CHRONIC PAIN TREATMENT MARKET SNAPSHOT

FIG 50 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2015–2030)

FIG 51 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2015–2030)

FIG 52 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2015–2030)

FIG 53 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2015–2030)

FIG 54 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2015–2030)

FIG 55 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2015–2030)

FIG 56 PRODUCT BENCHMARKING OF KEY PLAYERS IN CHRONIC PAIN TREATMENT DRUGS MARKET

FIG 57 PRODUCT BENCHMARKING OF KEY PLAYERS IN CHRONIC PAIN TREATMENT DEVICES MARKET

FIG 58 ELI LILLY AND COMPANY – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)

FIG 59 GLAXOSMITHKLINE PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 60 PFIZER INC. – REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2020)

FIG 61 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)

FIG 62 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 63 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 64 NOVARTIS AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 65 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 66 ASTRAZENECA PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 67 BRISTOL-MYERS SQUIBB COMPANY – REVENUE SPLIT BY BRAND AND GEOGRAPHY (2020)

FIG 68 BECTON, DICKINSON AND COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 69 SANOFI S.A. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)